You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The USDA Food Safety and Inspection Service will use the company's 3M Molecular Detection System for pathogen detection.
The test is the first to be approved for the company's second-generation molecular detection system, but can also be run using the first-generation system alongside other existing assays.
Bruker said the new agreement would allow it to develop the platform for use in pathology labs, including building clinically validated content libraries.
Pacific Biosciences announced this week that it has reached the final developmental milestone of its commercialization and licensing agreement with Roche.
The 3M Molecular Detection Assay 2 – Listeria monocytogenes is 30 percent faster than the first-generation test.
Brainco Biopharma has been awarded
3M Food Safety said last week that its 3M Molecular Detection Assay Salmonella has received an extension of the current NF Validation certificate from ANFOR Certification.
NEW YORK (GenomeWeb News) – Bruker said today it has signed an exclusive patent license agreement with 3M Company that allows it to include in its products patented 3M technology related to MALDI mass spec imaging.
The UK's Medical Research Council has been awarded US Patent No. 8,435,775, "Mutant Pfu DNA polymerase."
Phillip Holliger, Nicola Ramsay, and Ann-Sofie Jemth are named as inventors.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.